UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|||
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, including zip code)
(
(Registrant’s telephone number, including area code)
Ole Maaloes Vej 3
DK-2200 Copenhagen N
Denmark
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trade Symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 – Submission of Matters to a Vote of Security Holders.
Galecto, Inc. (the “Company”) held its annual meeting (the “Annual Meeting”) of stockholders on June 14, 2023. The following proposals were submitted to the stockholders at the Annual Meeting:
The proposals are described in detail in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 28, 2023.
The number of shares of common stock entitled to vote at the Annual Meeting was 25,673,474. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 16,122,362. All matters submitted to a vote of the Company’s stockholders at the Annual Meeting were approved and all director nominees were elected.
The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below:
Director Nominee |
|
Votes For |
|
Votes Withheld |
Jayson Dallas, M.D. |
|
9,917,146 |
|
696,399 |
Amit Munshi |
|
10,526,701 |
|
86,844 |
Hans Schambye, M.D., Ph.D. |
|
10,508,799 |
|
104,746 |
There were 5,508,817 broker non-votes regarding the election of directors.
Stockholders ratified the appointment of EY Godkendt Revisionspartnerselskab as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the voting included 16,042,725 votes for, 52,661 votes against and 26,976 votes abstained. There were no broker non-votes regarding this proposal.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Galecto, Inc. |
||
|
|
|
|
|||
Date: June 15, 2023 |
|
|
|
By: |
|
/s/ Hans T. Schambye |
|
|
|
|
|
|
Hans T. Schambye, M.D., Ph.D. |
|
|
|
|
|
|
President and Chief Executive Officer |